RemeGen Co. Ltd. Class H (9995)
9995 · Health Care · 
China
RemeGen Co. Ltd. Class H (9995) is a company in the Health Care sector, based in China. The stock is held in 10 ETFs we track – with its largest weight of 0.07 % in XCS6 (msci-china). Anyone holding one of these ETFs also owns a small indirect stake in RemeGen.
How many funds hold this stock?
Average ETF coverage: 10 of the 95 ETFs we cover hold RemeGen, spread across 5 indices. That puts the stock in more ETFs than 64.5 % of the 4,334 stocks we cover.
The line counts the funds we cover, not the market. Dashed: how many funds published a holdings list on that date.
What ETF is RemeGen in?
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XCS6 / XCS7 | msci-china | 0.07 % | €0.70 |
| SPYM | msci-em | 0.01 % | €0.10 |
| IS3N | msci-em-imi | 0.01 % | €0.10 |
| XMME / XEMD | msci-em | 0.01 % | €0.10 |
| SPYI / SPSA | msci-acwi-imi | 0.00 % | €0.00 |
| SPYY | msci-acwi | 0.00 % | €0.00 |
| IUSQ | msci-acwi | 0.00 % | €0.00 |
The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to RemeGen as of the fund's latest holdings list.
Weight in IS3N since 2024
In IS3N, a fund tracking the MSCI EM IMI, RemeGen had a weight of 0.00 % on Sep 30, 2024 and 0.01 % on Sep 18, 2026. Its share peaked at 0.02 % on Sep 30, 2025. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.
How much RemeGen Co. Ltd. Class H overlaps with other holdings in a portfolio is shown by the What's Inside Your ETF Portfolio and the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as RemeGen — the figure counts the ETFs holding both.
| Stock | Ticker | Shared ETFs | r |
|---|---|---|---|
| CSPC Pharmaceutical Group Limited | 1093 | 10 | – |
| Sinopharm Group Co. Ltd. Class H | 1099 | 10 | – |
| Sino Biopharmaceutical Limited | 1177 | 10 | – |
| 3SBio Inc. | 1530 | 10 | – |
| Genscript Biotech Corporation | 1548 | 10 | – |
| XtalPi Holdings Limited | 2228 | 10 | – |
 Hansoh Pharmaceutical Group Company Limited | 3692 | 10 | – |
| BeOne Medicines Ltd. | 6160 | 10 | – |
